DIETARY SUPPLEMENTS AND USE THEREOF ON MENSES
20200323940 ยท 2020-10-15
Assignee
Inventors
Cpc classification
A61K36/54
HUMAN NECESSITIES
A61K47/46
HUMAN NECESSITIES
A61K36/28
HUMAN NECESSITIES
A61K47/22
HUMAN NECESSITIES
A61K36/73
HUMAN NECESSITIES
A61K31/122
HUMAN NECESSITIES
A61K36/54
HUMAN NECESSITIES
A61K31/122
HUMAN NECESSITIES
A61K2300/00
HUMAN NECESSITIES
A61K2300/00
HUMAN NECESSITIES
A61K36/28
HUMAN NECESSITIES
A23L33/30
HUMAN NECESSITIES
A61P15/00
HUMAN NECESSITIES
A23L2/00
HUMAN NECESSITIES
International classification
A61K36/73
HUMAN NECESSITIES
A23L33/00
HUMAN NECESSITIES
A61K47/22
HUMAN NECESSITIES
Abstract
The invention relates to dietary supplements for use in the field of menstruation, in particular painful and heavy menstruation. The invention relates to a composition based on potentilla and iron.
Claims
1. A dietary supplement composition comprising, as percentage by weight: between 20% and 55% potentilla; and between 0.008% and 0.09% iron.
2. The composition according to claim 1, wherein a daily dose of potentilla weighs between 0.25 g to 7 g, preferably a daily dose of potentilla weighs between 4 to 6 g.
3. The composition according to claim 1, wherein a daily dose of iron weighs between 1 mg and 14 mg, preferably a daily dose of iron weighs between 2 mg and 7 mg.
4. The composition according to claim 1, comprising ginger at a percentage by weight of between 3% and 25%.
5. The composition according to claim 4, wherein a daily dose of ginger weighs between 0.25 g and 4 g, preferably a daily dose of ginger weighs between 1 g and 2 g.
6. The composition according to claim 1, comprising vitamin E or vitamin K at a percentage of less than 0.1%.
7. The composition according to claim 6, comprising vitamin E at a percentage by weight of between 0.008% and 0.06%, preferably a daily dose of vitamin E weighs between 1 mg and 15 mg.
8. The composition according to claim 6, comprising vitamin K at a percentage by weight of between 0.0001% and 0.0005%, preferably a daily dose of vitamin K weighs between 10 g and 75 g.
9. The composition according to claim 1, comprising yarrow at a percentage by weight of between 15% and 70%.
10. The composition according to claim 9, wherein a daily dose of yarrow weighs between 0.15 g and 15 g.
11. The composition according to claim 1, comprising a cinnamon extract at a percentage by weight of between 10% and 25%.
12. The composition according to claim 11, wherein a daily dose of the cinnamon extract weighs between 0.5 g and 2 g.
13. The composition according to claim 1, comprising a pomegranate extract at a percentage by weight of between 15% to 45%, and preferably the pomegranate extract has a percentage by weight of between 20% to 25%.
14. The composition according to claim 13, wherein a daily dose of the pomegranate extract weighs between 1 g and 4 g, and preferably a daily dose of the pomegranate extract weighs between 1.5 g and 2.5 g.
15. The composition according to claim 7, for the use thereof in the treatment of painful menstruation.
16. The composition according to claim 2, wherein a daily dose of iron weighs between 1 mg and 14 mg, preferably a daily dose of iron weighs between 2 mg and 7 mg.
17. The composition according to claim 2, comprising ginger at a percentage by weight of between 3% and 25%.
18. The composition according to claim 3, comprising ginger at a percentage by weight of between 3% and 25%.
19. The composition according to claim 2, comprising vitamin E or vitamin K at a percentage of less than 0.1%.
20. The composition according to claim 3, comprising vitamin E or vitamin K at a percentage of less than 0.1%.
Description
EXAMPLES
[0078] In order to illustrate the dietary supplement composition according to the invention, the applicant provides embodiments of the invention hereafter.
[0079] Firstly, examples 1 to 5 of tables 1 to 3 below correspond to embodiments, in accordance with the invention, of a dietary supplement composition for alleviating painful menstruation.
TABLE-US-00001 TABLE 1 Example 1 Example 2 Dose/day % Dose/day % Compounds (grams) by weight (grams) by weight Potentilla 0.5 22.21 6 37.47 anserina Iron 0.001 0.04 0.014 0.09 Pomegranate 1 44.42 4 24.98 extract Cinnamon 0.5 22.21 2 12.49 extract Ginger 0.25 11.11 4 24.98 Vitamin K 0.00001 0.0004 0.000075 0.0005 Totals 2.25101 100.00 16.014075 100.00
TABLE-US-00002 TABLE 2 Example 3 Example 4 Dose/day % Dose/day % Compounds (grams) by weight (grams) by weight Potentilla 4 53.32 6 49.97 anserina Iron 0.002 0.03 0.007 0.06 Pomegranate 1.5 19.99 2.5 20.82 extract Cinnamon 1 13.33 1.5 12.49 extract Ginger 1 13.33 2 16.66 Vitamin K 0.00001125 0.0001 0.0000375 0.0003 Totals 7.502 100 12.007 100
[0080] Example 5 in table 3 below is a dietary supplement composition suitable for alleviating heavy menstruation. The dose is administered in the form of tablets.
TABLE-US-00003 TABLE 3 PER % ACTUAL ACTIVE PER UNIT ACTIVE INGREDIENTS/D COMPONENTS 100 G (mg) INGREDIENTS (mg) OVERDOSAGE Ferrazone 2.02% 19.320 13.00% 10 Vitamin K1 at 1% 0.03% 0.325 1.00% 0.013 10% Rhizome ginger 3.95% 37.500 DE 5/1 Potentilla DE 4/1 26.32% 250.00 Microcrystalline 42.52% 403.913 cellulose 102 Heavy calcium 24.21% 230.00 37.24% 342.609 carbonate DC 95 MD Tricafos 200-7 0.95% 9.000 Carboxymethyl 0.00% 0.030 cellulose
[0081] Although the composition of example 5 is for alleviating heavy menstruation, it does not comprise either cinnamon extract or pomegranate extract.
[0082] Microcrystalline cellulose 102, heavy calcium carbonate DC 95 MD, Tricafos 200-7 and carboxymethyl cellulose are commercially available agents for manufacturing tablets.
[0083] The regular, preferably daily, for example, tablet form administration of the dietary supplement composition suitable for alleviating heavy menstruation helps to limit heavy menstruation. Preferably, the dosage regimen is more than 3 and preferably less than 5 units per day. A dosage regimen of 4 units per day makes it possible to remain within the recommended nutritional values for the majority of the elements of the composition (see table 3, actual active ingredients per day column). Each unit weighs 950 mg without film coating.
[0084] The tablets preferably have a longitudinal shape in order to facilitate ingestion. This may be a cylindrical shape with rounded bases.
[0085] More preferably, administration may be carried out over a period of 5 consecutive days ranging from 3 days before menstruation to 2 days after the start of menstruation. It is possible to contemplate a variant in which administration begins when symptoms appear and/or ends when symptoms disappear.
[0086] Examples 6 to 10, illustrated in tables 4 to 6 below, correspond to embodiments, according to the invention, of a dietary supplement composition for alleviating heavy menstruation.
TABLE-US-00004 TABLE 4 Example 6 Example 7 Dose/day % Dose/day % Compounds (grams) by weight (grams) by weight Potentilla 0.5 39.94 7 26.90 anserina Iron 0.001 0.08 0.014 0.05 Yarrow 0.5 39.94 15 57.63 Vitamin E 0.001 0.08 0.012 0.05 Ginger 0.25 19.97 4 15.37 Totals 1.252 100 26.026 100
TABLE-US-00005 TABLE 5 Example 8 Example 9 Dose/day % Dose/day % Compounds (grams) by weight (grams) by weight Potentilla 4 24.99 6 28.55 anserina Iron 0.002 0.01 0.007 0.03 Yarrow 11 68.73 13 61.87 Vitamin E 0.0018 0.01 0.006 0.03 Ginger 1 6.25 2 9.52 Totals 16.0038 100 21.013 100
Example 10
[0087] Example 10 is a dietary supplement composition suitable for alleviating painful menstruation. The dose is administered in the form of tablets.
TABLE-US-00006 TABLE 6 PER % ACTUAL ACTIVE PER UNIT ACTIVE INGREDIENTS/D COMPONENTS 100 G (mg) INGREDIENTS (mg) OVERDOSAGE Ferrazone 2.02% 19.320 13.00% 10 Vitamin E succinate 0.39% 3.717 77.36% 11.5 15% Yarrow 15.79% 150.000 Potentilla DE 4/1 26.32% 250.00 Microcrystalline 30.32% 288.022 cellulose 102 Heavy calcium 24.21% 230.000 37.24% 342.609 carbonate DC 95 MD Tricafos 200-7 0.95% 9.000 Carboxymethyl 0.00% 0.030 cellulose
[0088] The dietary supplement composition of example 10 is suitable for alleviating painful menstruation.
[0089] The dosage regimen is preferably similar to the dosage regimen of example 5, in particular, for example, involving taking four units per day. Each unit weighs 950 mg without film coating.
[0090] More preferably, administration may be carried out over a period of 5 consecutive days ranging from 3 days before menstruation to 2 days after the start of menstruation. It is possible to contemplate a variant in which the administration begins when symptoms appear and/or ends when symptoms disappear.